Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Seok Jin | - |
dc.contributor.author | Kang, Hye Jin | - |
dc.contributor.author | Kim, Jin Seok | - |
dc.contributor.author | Oh, Sung Yong | - |
dc.contributor.author | Choi, Chul Won | - |
dc.contributor.author | Lee, Soon Il | - |
dc.contributor.author | Won, Jong Ho | - |
dc.contributor.author | Kim, Min Kyoung | - |
dc.contributor.author | Kwon, Jung Hye | - |
dc.contributor.author | Mun, Yeung-Chul | - |
dc.contributor.author | Kwak, Jae-Yong | - |
dc.contributor.author | Kwon, Jung Mi | - |
dc.contributor.author | Hwang, In Gyu | - |
dc.contributor.author | Kim, Hyo Jung | - |
dc.contributor.author | Park, Jinny | - |
dc.contributor.author | Oh, Sukjoong | - |
dc.contributor.author | Huh, Jooryung | - |
dc.contributor.author | Ko, Young Hyeh | - |
dc.contributor.author | Suh, Cheolwon | - |
dc.contributor.author | Kim, Won Seog | - |
dc.date.accessioned | 2021-09-07T15:14:36Z | - |
dc.date.available | 2021-09-07T15:14:36Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-02-10 | - |
dc.identifier.issn | 0006-4971 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/113076 | - |
dc.description.abstract | The aim of this retrospective cohort study was to analyze the impact of surgery on the outcomes and qualities of life (QOL) in patients with intestinal diffuse large B-cell lymphoma (DLBCL). We assessed 345 patients with either localized or disseminated intestinal DLBCL and compared them according to treatment: surgical resection followed by chemotherapy versus chemotherapy alone. In patients with localized disease (Lugano stage I/II), surgery plus chemotherapy yielded a lower relapse rate (15.3%) than did chemo-therapy alone (36.8%, P < .001). The 3-year overall survival rate was 91% in the surgery plus chemotherapy group and 62% in the chemotherapy-alone group (P < .001). The predominant pattern in the chemotherapy group was local relapse (27.6%). When rituximab was used with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP), there was no improvement of the outcomes in patients treated with primary surgical resection. The QOL of patients who underwent surgery and chemotherapy was lower than chemotherapy alone, but its difference was acceptable. Multivariate analysis showed that surgical resection plus chemotherapy was an independent prognostic factor for overall survival. Surgical resection followed by chemotherapy might be an effective treatment strategy with acceptable QOL deterioration for localized intestinal DLBCL. This study was registered at www.clinicaltrials.gov as #NCT01043302. (Blood. 2011; 117(6): 1958-1965) | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER SOC HEMATOLOGY | - |
dc.subject | NON-HODGKINS-LYMPHOMA | - |
dc.subject | GIT NHL 01/92/ | - |
dc.subject | GASTROINTESTINAL-TRACT | - |
dc.subject | GERMAN MULTICENTER | - |
dc.subject | GASTRIC-LYMPHOMA | - |
dc.subject | CLINICAL-FEATURES | - |
dc.subject | MANAGEMENT | - |
dc.subject | PROGNOSIS | - |
dc.subject | CHOP | - |
dc.title | Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Chul Won | - |
dc.identifier.doi | 10.1182/blood-2010-06-288480 | - |
dc.identifier.scopusid | 2-s2.0-79951489806 | - |
dc.identifier.wosid | 000287192300031 | - |
dc.identifier.bibliographicCitation | BLOOD, v.117, no.6, pp.1958 - 1965 | - |
dc.relation.isPartOf | BLOOD | - |
dc.citation.title | BLOOD | - |
dc.citation.volume | 117 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1958 | - |
dc.citation.endPage | 1965 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordPlus | NON-HODGKINS-LYMPHOMA | - |
dc.subject.keywordPlus | GIT NHL 01/92/ | - |
dc.subject.keywordPlus | GASTROINTESTINAL-TRACT | - |
dc.subject.keywordPlus | GERMAN MULTICENTER | - |
dc.subject.keywordPlus | GASTRIC-LYMPHOMA | - |
dc.subject.keywordPlus | CLINICAL-FEATURES | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordPlus | CHOP | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.